Lewandowicz J
Z Zespołu Reumatologicznego Instytutu Medycyny Wewnetrznej AM w Lodzi.
Pol Tyg Lek. 1990;45(23-24):471-2.
Calf thymus preparation (TFX-Polfa) was administered + to 25 patients with classic rheumatoid arthritis in the II and III phase of the disease. Only patients not tolerating gold or D-penicillamine because of allergy or other complications, were included into the study. TFX was administered in a daily dose of 10 mg TFX protein i.m. for 60 consecutive days, followed by the treatment in outpatient clinic for successive++ 10 months. Statistically significant increase in the hemoglobin concentration and erythrocyte counts was produced by both a 2-month intensive treatment and a 12-month of therapy with TFX.
对25例处于疾病II期和III期的典型类风湿性关节炎患者给予小牛胸腺制剂(TFX - Polfa)。仅纳入因过敏或其他并发症而不耐受金制剂或D - 青霉胺的患者进行研究。TFX的给药剂量为每日10mg TFX蛋白,肌肉注射,连续60天,随后在门诊进行连续10个月的治疗。2个月的强化治疗和12个月的TFX治疗均使血红蛋白浓度和红细胞计数产生了统计学上的显著增加。